The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer.
Da Hyun KangSeong-Woo ChoiPureum SunChaeuk ChungDong Il ParkSong I LeeJeong Suk KohYoonjoo KimJeong Eun LeePublished in: Thoracic cancer (2022)
Time interval from chemotherapy to immunotherapy may affect immune cell status and efficacy of ICIs.